FDA Approved: XELSTRYM — Supplemental Application (Noven Therapeutics, LLC)

View source ↗

Summary

The FDA approved a supplemental application for XELSTRYM (dextroamphetamine) submitted by Noven Therapeutics, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Drugs mentioned

• XELSTRYM (Dextroamphetamine)

Snippet

SUPPL AP for XELSTRYM (DEXTROAMPHETAMINE)